Skip to content

The SaeboGlove Evaluation Trial

The SaeboGlove Evaluation Trial in Stroke

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03036033
Acronym
T-SET
Enrollment
12
Registered
2017-01-30
Start date
2017-01-26
Completion date
2017-07-25
Last updated
2017-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, Cerebral Vascular Disorder, Nervous System Diseases, Stroke, Vascular Diseases

Brief summary

This study evaluates the safety, feasibility and usability of a SaeboGlove rehabilitation device in the treatment of patients who have reduced ability to open their hand due to weakness after an acute stroke.

Detailed description

The SaeboGlove is a new rehabilitation aid that can be used in people with hand weakness after a neurological injury. It assists the hand to open, which is crucial for people to grasp, and release everyday objects. It may improve function by doing this but may also help people with severe weakness take part more fully in therapy sessions. This glove is already marketed and is being used in some NHS sites. This trial will assess how it could be used in NHS practice in acute stroke patients and will develop a plan to implement this.

Interventions

DEVICESaeboGlove

All participants are given a Saebo glove to use during their stroke recovery.

Sponsors

University of Glasgow
CollaboratorOTHER
NHS Greater Glasgow and Clyde
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Intervention model description

Single group, open feasibility study of use of a CE marked and available device.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Able to consent 2. Aged ≥18 years 3. Diagnosis of stroke occurring ≤30 days ago 4. Reduced active range of movement wrist and / or finger extension 5. Modified ashworth score at wrist and fingers ≤ 2 6. Some initiation of gross active finger flexion 7. At least 10 degrees passive range of motion wrist extension 8. Considered able to learn to don / doff a SaeboGlove +/- help of willing carer 9. Ability to engage in some independent rehabilitation +/- help of willing carer 10. Considered able to comply with the requirements of protocol?

Exclusion criteria

1. Presence of \>5-10 degrees digital contractures 2. Presence of other upper limb impairment that would influence participation (e.g. fixed contracture, frozen shoulder, severe arthritis or upper limb pain) 3. Presence of other conditions likely to influence participation (e.g. medically unstable, registered blind, terminal cancer, severe mood, cognitive or language issues) 4. Participating in another stroke rehabilitation trial

Design outcomes

Primary

MeasureTime frameDescription
Number of sessions performed using the SaeboGloveOne monthFeasibility

Secondary

MeasureTime frameDescription
Participant, Carer and Therapist Usability and Training QuestionnaireOne monthBespoke questionnaire
Box and Block TestOne monthMeasure to assess gross dexterity
Therapy IntensityCumulative over one monthNumber of movement repetitions performed using the SaeboGlove
Motor Activity Log (MAL)One monthInterview intended to examine how much and how well the participant uses arm
Number of adverse events related to using the SaeboGloveOne monthSafety
Action Research Arm Test (ARAT)One monthMeasure to assess arm function

Countries

United Kingdom

Contacts

Primary ContactJen Alexander
jen.alexander@ggc.scot.nhs.uk0141 451 5870
Backup ContactDr Jesse Dawson
Jesse.Dawson@glasgow.ac.uk0141 451 5868

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026